Overview

A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)

Status:
Completed

Trial end date:
2015-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is investigate mycophenolic acid exposure through area under the curve in renal transplants recipients treated with mycophenolate mofetil and after conversion to mycophenolate sodium.

Phase:

Phase 4

Details

Lead Sponsor:

Irmandade Santa Casa de Misericórdia de Porto Alegre

Collaborator:

Novartis

Treatments:

Calcineurin Inhibitors
Mycophenolate mofetil
Mycophenolic Acid